|
The new specialist firm will operate across the North American, APAC and European markets, which make up around 90% of the global R&D spend.
|
 |
|
Lilly’s takeover of Engage Bio marks the seventh acquisition for the big pharma since the start of 2026.
|
|
|
BMS will roll out Claude to over 30,000 employees, targeting three main areas for near-term impact.
|
|
|
The site includes laboratories for cell culture manufacturing, process development, and a centre focused on gene editing.
|
|
|
PABPC4 genetic variants found to be associated with mitochondrial dysfunction driving emphysema in COPD.
|
|
|
48 weeks of Trikafta treatment improved lung capacity and inflammation biomarkers among CF patients.
|
|
